142 related articles for article (PubMed ID: 1493193)
1. Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats.
Bazile DV; Ropert C; Huve P; Verrecchia T; Marlard M; Frydman A; Veillard M; Spenlehauer G
Biomaterials; 1992; 13(15):1093-102. PubMed ID: 1493193
[TBL] [Abstract][Full Text] [Related]
2. Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.
Landry FB; Bazile DV; Spenlehauer G; Veillard M; Kreuter J
J Drug Target; 1998; 6(4):293-307. PubMed ID: 9894697
[TBL] [Abstract][Full Text] [Related]
3. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
Bazile D; Prud'homme C; Bassoullet MT; Marlard M; Spenlehauer G; Veillard M
J Pharm Sci; 1995 Apr; 84(4):493-8. PubMed ID: 7629743
[TBL] [Abstract][Full Text] [Related]
4. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.
Verrecchia T; Huve P; Bazile D; Veillard M; Spenlehauer G; Couvreur P
J Biomed Mater Res; 1993 Aug; 27(8):1019-28. PubMed ID: 8408114
[TBL] [Abstract][Full Text] [Related]
5. Degradation of poly(D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII).
Landry FB; Bazile DV; Spenlehauer G; Veillard M; Kreuter J
Biomaterials; 1996 Apr; 17(7):715-23. PubMed ID: 8672634
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
Liu M; Li H; Luo G; Liu Q; Wang Y
Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
[TBL] [Abstract][Full Text] [Related]
7. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
8. Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).
Sasatsu M; Onishi H; Machida Y
Int J Pharm; 2008 Jun; 358(1-2):271-7. PubMed ID: 18448290
[TBL] [Abstract][Full Text] [Related]
9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
10. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
[TBL] [Abstract][Full Text] [Related]
11. The metabolic fate of the Anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats.
Swart PJ; Kuipers ME; Smit C; Beljaars L; Ter Wiel J; Meijer DK
J Drug Target; 2001 Apr; 9(2):95-109. PubMed ID: 11697111
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 99mTc labelled poly lactic acid microspheres for diagnostic radioembolization.
Ergün EL; Ercan MT; Selek H; Kaş HS; Ruacan S; Unsal IS; Mutlu M
J Microencapsul; 2000; 17(4):509-18. PubMed ID: 10898090
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
[TBL] [Abstract][Full Text] [Related]
14. Layer-by-layer polyelectrolyte coating of low molecular weight poly(lactic acid) nanoparticles.
Hirsjärvi S; Peltonen L; Hirvonen J
Colloids Surf B Biointerfaces; 2006 Apr; 49(1):93-9. PubMed ID: 16616460
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of insulin from plasma-irradiated sandwitch device using poly-DL-lactic acid.
Yamakawa I; Watanabe S; Matsuno Y; Kuzuya M
Biol Pharm Bull; 1993 Feb; 16(2):182-7. PubMed ID: 8364454
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of zwitterionic phospholipid polymer-coated poly(lactic acid) nanoparticles.
Bao LL; Huang HQ; Zhao J; Nakashima K; Gong YK
J Biomater Sci Polym Ed; 2014; 25(14-15):1703-16. PubMed ID: 25183528
[TBL] [Abstract][Full Text] [Related]
17. [Drug distribution and antitumor effect of bleomycin incorporated in poly DL-lactic acid in rats].
Kumanohoso T; Natsugoe S; Tokuda K; Shimada M; Sagara M; Shinkawa T; Nakamura K; Yamada K; Fukuzaki H; Aikou T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2248-50. PubMed ID: 7524449
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
19. In vivo activity of bleomycin incorporated with biodegradable poly-d,l-lactic acid and implanted in the mediastinum of dogs.
Kumanohoso T; Natsugoe S; Shimada M; Aikou T; Nakamura K; Yamada K; Fukuzaki H
J Surg Oncol; 1994 Nov; 57(3):178-82. PubMed ID: 7526072
[TBL] [Abstract][Full Text] [Related]
20. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
